Abstract

Macular pigment is a yellowish pigment of purely dietary origin, which is thought to have a protective role in the retina. Recently, it was linked to age-related macular degeneration and improved visual function. In this work, we present a method and a corresponding optical instrument for the rapid measurement of its optical density. The method is based on fundus reflectometry and features a photodetector for the measurement of reflectance at different wavelengths and retinal locations. The method has been tested against a commercially available instrument on a group of healthy volunteers and has shown good correlation. The proposed instrument can serve as a rapid, non-midriatic, low-cost tool for the measurement of macular pigment optical density.

Highlights

  • Macular Pigment (MP) is a collective term for the carotenoids lutein, zeaxanthin and mesozeaxanthin

  • Macular pigment has been related to visual function; studies suggest that higher density is linked to improved visual performance, acuity [6, 7]

  • Equation (3) gives the non-normalised spatial distribution of Macular Pigment Optical Density (MPOD) in the retina, i.e. the value of MPOD is given in arbitrary units.In order to differentiate this value from the quantitative MPOD measurement using the Fourier method, the non-normalised MPOD value was denoted with a star

Read more

Summary

Introduction

Macular Pigment (MP) is a collective term for the carotenoids lutein, zeaxanthin and mesozeaxanthin. A study has shown that lutein due to its anti-inflammatory action can prevent choroidal neovascularisation [3]. Recent findings suggest that the optical density of macular pigment is significantly lower in case of degenerative macular diseases such as age-related macular degeneration (AMD) [4, 5], further supporting the protective hypothesis. Macular pigment has been related to visual function; studies suggest that higher density is linked to improved visual performance, acuity [6, 7]. Recent studies have seen a relation between the MP distrubution and macular telangiectasia type 2 [8, 9]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.